Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,941 | 190 | 73.4% |
| Travel and Lodging | $1,358 | 4 | 25.3% |
| Education | $69.90 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,759 | 15 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $806.77 | 50 | $0 (2024) |
| Novo Nordisk Inc | $427.41 | 32 | $0 (2024) |
| Lilly USA, LLC | $352.07 | 21 | $0 (2024) |
| Allergan, Inc. | $261.43 | 5 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $218.33 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $174.18 | 11 | $0 (2023) |
| Impulse Dynamics (USA) Inc. | $159.90 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $159.48 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $149.20 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $630.03 | 30 | AstraZeneca Pharmaceuticals LP ($154.51) |
| 2023 | $1,026 | 47 | Impulse Dynamics (USA) Inc. ($159.90) |
| 2022 | $586.36 | 33 | AstraZeneca Pharmaceuticals LP ($164.79) |
| 2021 | $598.71 | 38 | AstraZeneca Pharmaceuticals LP ($179.18) |
| 2020 | $258.18 | 14 | AstraZeneca Pharmaceuticals LP ($101.78) |
| 2019 | $295.44 | 15 | Janssen Pharmaceuticals, Inc ($104.16) |
| 2018 | $1,715 | 12 | Amgen Inc. ($1,655) |
| 2017 | $259.94 | 7 | Allergan Inc. ($176.25) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 2 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Respiratory | ||||||
| 03/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DIABETES | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.56 | General |
| 12/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Endocrinology | ||||||
| 12/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Inflammation | ||||||
| 12/01/2023 | KCI USA, Inc. | ACTIV.A.C. iOn PROGRESS (Device), PREVENA, V.A.C. VERAFLO | Food and Beverage | Cash or cash equivalent | $89.84 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 11/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardio-renal | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.12 | General |
| 10/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation | ||||||
| 09/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Interventional Urology | ||||||
| 08/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.61 | General |
| 08/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 575 | 859 | $178,734 | $53,098 |
| 2022 | 8 | 314 | 753 | $100,002 | $44,426 |
| 2021 | 9 | 333 | 828 | $76,704 | $43,148 |
| 2020 | 10 | 296 | 761 | $81,331 | $39,053 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 362 | $106,924 | $27,959 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 135 | $27,551 | $7,803 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $16,114 | $4,495 | 27.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 62 | 62 | $3,705 | $3,630 | 98.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $8,508 | $3,390 | 39.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 71 | $2,020 | $1,942 | 96.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $5,522 | $1,717 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $4,384 | $796.66 | 18.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 63 | $2,431 | $747.29 | 30.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $328.20 | $321.60 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $883.42 | $224.82 | 25.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 24 | 61 | $366.00 | $72.47 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 369 | $74,556 | $35,098 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 43 | $8,597 | $3,045 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,686 | $2,028 | 35.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,260 | $1,236 | 98.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 101 | $3,746 | $1,158 | 30.9% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 53 | 80 | $2,000 | $1,086 | 54.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $935.20 | $657.90 | 70.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 33 | 97 | $3,221 | $116.56 | 3.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 352 | $57,004 | $34,355 | 60.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 40 | 40 | $2,636 | $2,601 | 98.7% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2021 | 57 | 143 | $3,575 | $1,927 | 53.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,250 | $1,724 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 43 | 43 | $1,505 | $800.66 | 53.2% |
About Dr. Anjali Shah, MD
Dr. Anjali Shah, MD is a Family Medicine healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831101757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anjali Shah, MD has received a total of $5,369 in payments from pharmaceutical and medical device companies, with $630.03 received in 2024. These payments were reported across 196 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,941).
As a Medicare-enrolled provider, Shah has provided services to 1,518 Medicare beneficiaries, totaling 3,201 services with total Medicare billing of $179,725. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Newburgh, NY
- Active Since 08/12/2006
- Last Updated 06/17/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831101757
Products in Payments
- Repatha (Biological) $1,628
- FARXIGA (Drug) $685.06
- TRADJENTA (Drug) $218.33
- TRULICITY (Drug) $165.53
- OPTIMIZER (Device) $159.90
- Cologuard Collection Kit (Device) $141.58
- MOUNJARO (Drug) $133.58
- XARELTO (Drug) $131.29
- ANORO (Drug) $131.13
- BOTOX-UROLOGY (Drug) $109.37
- Ozempic (Drug) $97.08
- Rybelsus (Drug) $96.47
- DIFICID (Drug) $95.42
- XIFAXAN (Drug) $92.58
- ACTIV.A.C. iOn PROGRESS (Device) $89.84
- Xhance (Drug) $82.35
- BOTOX COSMETIC (Biological) $69.90
- NAMZARIC (Drug) $66.88
- Kerendia (Drug) $64.63
- Otezla (Drug) $63.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newburgh
Renee Galen, Md, MD
Family Medicine — Payments: $21,104
Shannon Kratzer, Fnp, FNP
Family Medicine — Payments: $10,562
Megan Missaggia, M.d, M.D
Family Medicine — Payments: $8,222
Gary Riddle, M.d, M.D
Family Medicine — Payments: $7,372
Elise Schutt, Fnp, FNP
Family Medicine — Payments: $7,199
Jennifer Simoneaux, M.d, M.D
Family Medicine — Payments: $6,872